TUHR10TKBHomo sapiens (Human)Cancer cell line

Also known as: OgTs, TUHR-10TKB

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_5952
SpeciesHomo sapiens (Human)
Tissue SourceKidney[UBERON:UBERON_0002113]

Donor Information

Age69
Age CategoryAdult
SexMale

Disease Information

DiseaseClear cell renal carcinoma
LineageKidney
SubtypeRenal Clear Cell Carcinoma
OncoTree CodeCCRCC

DepMap Information

Source TypeRIKEN
Source IDACH-000459_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,12
D13S317
14
D16S539
13
D5S818
9,12
D7S820
10,11
TH01
9
TPOX
8,11
vWA
14,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.

Hsieh J.J.-D., Hakimi A.A.

Nat. Commun. 8:15165.1-15165.10(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines.

Nakamura K., Honda N., Hinotsu S., Miyazaki J., Kunita N., Akaza H.

Cancer Sci. 98:529-534(2007).

High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.

Shiba R., Saijo K., Ohno T.

Jpn. J. Cancer Res. 89:1195-1201(1998).